RESEARCH FUNDING
We've invested over 2.5 million dollars in preeclampsia research
Last Updated on August 28, 2025
RESEARCH FUNDING
Peter Joseph Pappas Research Grant Program
June 2026 - The 2026 Peter Joseph Pappas Research Grant LOI application process is now open.
The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research. The ultimate goal of this grant program is to drive research that will eliminate the delivery of pre-term babies as an intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy. Named for the infant son of preeclampsia survivor Lauren Pappas and her husband Clement, the program seeks to award multiple two-year grants in 2025 totaling up to $200,000.
Complete application instructions can be found here. Letters of intent are due by Friday, August 14, 2026 by 5:00 pm ET submitted via Proposal Central.
Read more about the Peter Joseph Pappas Research Grant Program.
Questions? Contact PJPGrants@preeclampsia.org
PREVIOUS PETER JOSEPH PAPPAS GRANT RECIPIENTS
The Vision Grant Award Program
March 2026 - The Preeclampia Foundation Vision Grant Applications are now closed.
About Vision Grants: Vision Grants are intended to provide initial funding for novel, innovative research by promising young investigators that will advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. Post-doctoral, Clinical Fellows, or Early Stage Investigators only are eligible to apply. Projects with potential to alter clinical management and improve patient outcomes will receive priority, but any well-considered research proposal will be accepted for review. International applications are welcome; however, submissions must be in English. The Foundation has committed to funding grants that address known research knowledge gaps.
Questions? Contact VisionGrants@preeclampsia.org
PREVIOUS VISION GRANT RECIPIENTS
More Information
- Read final reports from our funded investigators, as well as the published results of our research, here.
- Sign up to receive immediate announcements about research funding and our monthly Research Roundup, here.
Researchers, please contact our Research Manager if you would like the Preeclampsia Foundation to help you recruit participants for a research study or focus group, or have any questions about the Preeclampsia Registry.
- 2024 Vision Grants
- 2023 Vision Grants
- 2022 Vision Grants
- 2021 Vision Grant
- 2019 Vision Grants
- 2018 Vision Grants
- 2017 Vision Grants
- 2016 Vision Grants
- 2015 Vision Grants
- 2014 Vision Grants
- 2013 Vision Grants
- 2012 Vision Grants
- 2011 Vision Grants
- 2010 Vision Grants
- 2009 Vision Grants
- 2008 Vision Grants
- 2007 Vision Grants
- 2002 Vision Grant
Related Articles
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research. The ultimate goal of this grant prog...
1779989418.png)
Preeclampsia is a disorder that affects all the body’s systems, and the brain is no exception. Neurological manifestations of preeclampsia are very common and in fact are some of the “seve...
1777566412.png)
Placental dysfunction can result in conditions such as preeclampsia, which have traditionally been managed with close monitoring and appropriately timed delivery. There is currently no cure for preecl...
1777563523.png)
Gestational hypertension continues to be a growing public health concern contributing to maternal morbidity, mortality, and long-term health complications in the U.S. While changes in vision—suc...
1777562643.png)
Background Low-dose aspirin (81 mg) is a treatment known to help lower the risk of preeclampsia. However, not everyone who is at higher risk is told to take it. This study looks at whether a screening...